Atossa Therapeutics
ATOS
#10737
Rank
ยฃ16 M
Marketcap
ยฃ1.60
Share price
0.47%
Change (1 day)
151.45%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ28.24 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ26.06 Million a decrease over its 2024 earnings that were of -ยฃ19.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ28.24 Million8.38%
2025 -ยฃ26.06 Million36.33%
2024 -ยฃ19.11 Million-15.25%
2023 -ยฃ22.55 Million11.62%
2022 -ยฃ20.2 Million30.84%
2021 -ยฃ15.44 Million15.58%
2020 -ยฃ13.36 Million3.41%
2019 -ยฃ12.92 Million51.16%
2018 -ยฃ8.55 Million40.41%
2017 -ยฃ6.09 Million27.54%
2016 -ยฃ4.78 Million-47.49%
2015 -ยฃ9.09 Million-17.25%
2014 -ยฃ10.99 Million35.91%
2013 -ยฃ8.09 Million112.3%
2012 -ยฃ3.81 Million46.53%
2011 -ยฃ2.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.02 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.11 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.09 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.22 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ24.68 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.88 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA